From July 1, 2023 to July 13, 2023, the company has repurchased 0 shares, representing 0% for CNY 0 million. With this, the company has completed the repurchase of 14,523,100 shares, representing 2.57% for CNY 79.72 million under the buyback announced on July 15, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5.19 CNY | +0.78% | -1.89% | -15.33% |
1st Jan change | Capi. | |
---|---|---|
-15.33% | 400M | |
+34.35% | 705B | |
+30.74% | 583B | |
-3.49% | 364B | |
+20.15% | 332B | |
+6.19% | 291B | |
+15.81% | 238B | |
-3.44% | 210B | |
+10.38% | 209B | |
+9.21% | 169B |
- Stock Market
- Equities
- 600222 Stock
- News Henan Taloph Pharmaceutical Stock Co.,Ltd
- Tranche Update on Henan Taloph Pharmaceutical Stock Co.,Ltd's Equity Buyback Plan announced on July 15, 2022.